Clinical Edge Journal Scan

Cognitive function significantly altered in PsA


 

Key clinical point: Cognitive abilities were altered in patients with psoriatic arthritis (PsA) compared with non-rheumatology reference individuals, with significant impairment in selective attention.

Major finding: Patients with PsA reported significant deficits in selective attention (mean difference [MD] −4.5), no effect on working memory (P = .662) and improvement in episodic short-term memory (MD 3.0; both P < .001) compared with matched reference subjects.

Study details: Findings are from a cross-sectional, exploratory study including 101 patients with axial spondyloarthritis, 117 patients with PsA, and matched non-rheumatology reference subjects without any diseases relevant to cognitive performance.

Disclosures: This study was funded by the RHADAR GbR, Germany. Some authors, including the lead author, declared receiving grants, consulting fees, speaker’s fees, travel support, honoraria, or advisory board support from several sources.

Source: Kleinert S et al. Impairment in cognitive function in patients with axial spondyloarthritis and psoriatic arthritis. Rheumatol Int. 2022 (Nov 28). Doi: 10.1007/s00296-022-05248-4

Recommended Reading

Wide variance described in lab monitoring of conventional synthetic DMARDs
MDedge Rheumatology
Skinny-label biosimilars provide substantial savings to Medicare
MDedge Rheumatology
Commentary: Sex differences, pregnancy, a quicker CRP test, and new drugs in PsA, December 2022
MDedge Rheumatology
Vaccination cuts long COVID risk for rheumatic disease patients
MDedge Rheumatology
Bimekizumab shows promise in PsA patients naive to bDMARD
MDedge Rheumatology
BNT162b2 booster dose highly recommended for PsA patients on TNF inhibitors
MDedge Rheumatology
Bimekizumab beneficial in PsA patients with inadequate response to or intolerance of TNFα inhibitors
MDedge Rheumatology
Nailfold capillary abnormalities predict PsA in patients with psoriasis
MDedge Rheumatology
Understanding the bidirectional causal link between Crohn’s disease and PsA
MDedge Rheumatology
Greater joint damage and higher disease activity increases risk for surgery in PsA
MDedge Rheumatology